Review of the registration of clinical trials in UMIN-CTR from 2 June 2005 to 1 June 2010 - focus on Japan domestic, academic clinical trials

Trials

Volumn 14, Issue 1, 2013, Pages

  Tang, Wentao ^a   Fukuzawa, Manabu ^a   Ishikawa, Hirono ^a,b   Tsutani, Kiichiro ^a   Kiuchi, Takahiro ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

Accessibility; Clinical trial registration; Comparative effectiveness research; Non industry funded trial; Results publication; UMIN CTR

Indexed keywords

ARTICLE; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); HUMAN; JAPAN; JAPANESE; MEDICAL INFORMATION; MEDICAL LITERATURE; PRACTICE GUIDELINE; REGISTER; REGISTRATION; SCREENING; UNIVERSITY HOSPITAL;

ACCESS TO INFORMATION; CLINICAL TRIALS AS TOPIC; COMPARATIVE EFFECTIVENESS RESEARCH; DATA MINING; DATABASES, FACTUAL; HOSPITALS, UNIVERSITY; HUMANS; JAPAN; LANGUAGE; REGISTRIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84885368641     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-14-333     Document Type: Article

References (43)

1. Dickersin K, Min YI. Publication bias: the problem that won't go away. Ann N Y Acad Sci 1993, 703:135-146. 10.1111/j.1749-6632.1993.tb26343.x, 8192291.
2. Chan AW, Hróbjartsson A, Haahr MT, Gøtzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 2004, 291(20):2457-2465. 10.1001/jama.291.20.2457, 15161896.
3. Al-Marzouki S, Roberts I, Evans S, Marshall T. Selective reporting in clinical trials: analysis of trial protocols accepted by The Lancet. Lancet 2008, 372(9634):201.
4. Dickersin K, Rennie D. Registering clinical trials. JAMA 2003, 290(4):516-523. 10.1001/jama.290.4.516, 12876095.
5. Levine J, Guy W, Cleary P. Therapeutic trials of psychopharmacologic agents: 1968-1972. Psychopharmacological Agent 1974, Armonk, NY: Futura Publishing Co, McMahon GA.
6. Simes RJ. Publication bias: the case for an international registry of clinical trials. J Clin Oncol 1986, 4(10):1529-1541.
7. Missing drug data. Washington Post 30 June 2004, A20.
8. When drug companies hide data. New York Times 6 June 2004, (Sect 4):12.
9. De Angelis CD, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, Kotzin S, Laine C, Marusić A, Overbeke AJ, Schroeder TV, Sox HC, Van Der Weyden MB. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. Lancet 2004, 364(9438):911-912. 10.1016/S0140-6736(04)17034-7, 15364170.
10. Krleza-Jerić K, Chan AW, Dickersin K, Sim I, Grimshaw J, Gluud C. Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1). BMJ 2005, 330(7497):956-958. 10.1136/bmj.330.7497.956, 556346, 15845980.
11. World Health Organization (WHO) WHA58.34 Ministerial Summit on Health Research 2005, Geneva: WHO, [http://apps.who.int/iris/bitstream/10665/20384/1/WHA58_34-en.pdf], World Health Organization (WHO).
12. International Clinical Trials Registry Platform (ICTRP) Search Portal [http://apps.who.int/trialsearch/].
13. International Clinical Trials Registry Platform (ICTRP) WHO Trial Registration Data Set (Version 1.2.1) [http://www.who.int/ictrp/network/trds/en/index.html], International Clinical Trials Registry Platform (ICTRP).
14. World Medical Association (WMA) WMA Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects 2008, Ferney-Voltaire: WHO, [http://www.wma.net/en/30publications/10policies/b3/], World Medical Association (WMA).
15. CONSORT Statement Item 23 - Registration number and name of trial registry [http://www.consort-statement.org/consort-statement/23-25---other-information0/], CONSORT Statement.
16. UMIN Clinical Trials Registry (UMIN-CTR) [http://www.umin.ac.jp/ctr/index-j.htm].
17. Shiokawa T. Background, introduction and activity of the Japan Primary Registries Network. J Evid Based Med 2009, 2(1):41-43. 10.1111/j.1756-5391.2009.01013.x, 21348982.
18. Japic-CTI [http://www.clinicaltrials.jp], Japic-CTI.
19. JMACCT [https://dbcentre3.jmacct.med.or.jp/jmactr/], JMACCT.
20. Yakuji Hoki Kenkyukai (The Society of Pharmaceutical Laws and Regulations) Roppozensyo (Compendium of the six codes) 2013, Tokyo: Gyosei Press, Yakuji Hoki Kenkyukai (The Society of Pharmaceutical Laws and Regulations).
21. Shin Iyakuhin Nado no Shiyo no Seiseki Nado ni Kansuru Cyosa Jisshi Keikakusyo ni tsu i te (the notification of protocol of use results surveys on new drugs) [http://www.japal.org/contents/19931228_113.pdf].
22. Yakubutsu no Chiken Keikaku Todokede Seido (the system of notification of Chiken protocol) [http://www.pmda.go.jp/operations/shonin/info/chikenkanren/chikentodoke.html].
23. International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) Global Industry Position On Disclosure of Information About Clinical Trials 2005, Geneva: IFPMA, [http://clinicaltrials.ifpma.org/clinicaltrials/fileadmin/files/pdfs/EN/CTP_Release_Joint_Position_EN.pdf], International Federation of Pharmaceutical Manufacturers & Associations (IFPMA).
24. International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) New Joint Industry Clinical Trials Transparency Position Requires Companies to Disclose All Clinical Trials in Patients 2009, Geneva: IFPMA, [http://www.jpma.or.jp/about/basis/rinsyo/pdf/091110_shishin_release_e.pdf], International Federation of Pharmaceutical Manufacturers & Associations (IFPMA).
25. Heisei 19 Nendo Koseirodo Kagaku Kenkyuhi Hojyokin Kobo Yoko (requirement for the application of Health and Labour Sciences Research Grants) [http://www.mhlw.go.jp/bunya/kenkyuujigyou/hojokin-koubo07b/index.html].
26. Rinsyo Kenkyuni Kansuru Rinri Shishin (ethical guidelines for clinical research) [http://www.mhlw.go.jp/general/seido/kousei/i-kenkyu/rinsyo/dl/shishin.pdf].
27. Tashiro S. Unintended consequences of " soft" regulations: the social control of human biomedical research in Japan. Int J Jpn Sociology 2010, 19(1):4-17.
28. Zarin DA, Tse T, Ide NC. Trial Registration at ClinicalTrials.gov between May and October 2005. N Engl J Med 2005, 353(26):2779-2787. 10.1056/NEJMsa053234, 1568386, 16382064.
29. ClinicalTrials.gov [http://www.clinicaltrials.gov].
30. Zarin DA, Tse T, Williams RJ, Califf RM, Ide NC. The ClinicalTrials.gov results database-update and key issues. N Engl J Med 2011, 364(9):852-860. 10.1056/NEJMsa1012065, 3066456, 21366476.
31. UMIN-CTR no Unei Hoshin (operation policy of UMIN-CTR) [http://www.umin.ac.jp/ctr/UMIN-CTR_Policy.htm].
32. UMIN-CTR Yogo no Setsumei (simple glossary of UMIN-CTR) [http://www.umin.ac.jp/ctr/UMIN-CTR_Yougo.htm].
33. Laine C, Horton R, DeAngelis CD, Drazen JM, Frizelle FA, Godlee F, Haug C, Hébert PC, Kotzin S, Marusic A, Sahni P, Schroeder TV, Sox HC, Van der Weyden MB, Verheugt FW. Clinical trial registration: looking back and moving ahead. Lancet 2007, 369(9577):1909-1911. 10.1016/S0140-6736(07)60894-0, 17560431.
34. Aratana Chiken Kaseika 5 ka Nen Keikaku (New 5-Years Clinical Trial Activation Plan) [http://www.mhlw.go.jp/shingi/2007/03/s0330-5.html].
35. Viergever RF, Ghersi D. The quality of registration of clinical trials. PLoS One 2011, 6(2):e14701. 10.1371/journal.pone.0014701, 3044717, 21383991.
36. Califf RM, Zarin DA, Kramer JM, Sherman RE, Aberle LH, Tasneem A. Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010. JAMA 2012, 307(17):1838-1847. 10.1001/jama.2012.3424, 22550198.
37. Sox HC, Greenfield S. Comparative effectiveness research: a report from the Institute of Medicine. Ann Intern Med 2009, 151(3):203-205. 10.7326/0003-4819-151-3-200908040-00125, 19567618.
38. Luce BR, Kramer JM, Goodman SN, Connor JT, Tunis S, Whicher D, Schwartz JS. Rethinking randomized clinical trials for comparative effectiveness research: the need for transformational change. Ann Intern Med 2009, 151(3):206-209. 10.7326/0003-4819-151-3-200908040-00126, 19567619.
39. Bourgeois FT, Murthy S, Mandl KD. Comparative effectiveness research: an empirical study of trials registered in ClinicalTrials.gov. PLoS One 2012, 7(1):e28820. 10.1371/journal.pone.0028820, 3253780, 22253698.
40. Mullins CD, Whicher D, Reese ES, Tunis S. Generating evidence for comparative effectiveness research using more pragmatic randomized controlled trials. Pharmacoeconomics 2010, 28(10):969-976. 10.2165/11536160-000000000-00000, 20831305.
41. Thorpe KE, Zwarenstein M, Oxman AD, Treweek S, Furberg CD, Altman DG, Tunis S, Bergel E, Harvey I, Magid DJ, Chalkidou K. A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. J Clin Epidemiol 2009, 62(5):464-475. 10.1016/j.jclinepi.2008.12.011, 19348971.
42. Hasselblatt H, Dreier G, Antes G, Schumacher M. The German Clinical Trials Register: challenges and chances of implementing a bilingual registry. J Evid Based Med 2009, 2(1):36-40. 10.1111/j.1756-5391.2009.01001.x, 21348981.
43. Sawata H, Tsutani K. Funding and infrastructure among large-scale clinical trials examining cardiovascular diseases in Japan: evidence from a questionnaire survey. BMC Med Res Methodol 2011, 11:148. 10.1186/1471-2288-11-148, 3228708, 22044508.